Neumora Therapeutics, Inc. (NMRA) Tops Q1 EPS by 4c

Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q1 EPS of ($0.42), $0.04 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.

You May Also Be Interested In

• Trend Micro Incorporated (4704:JP) (TMICY) PT Lowered to JPY5,900 at Goldman Sachs
• Hanmi Pharm licenses obesity drug to Genentech in $2.3B deal
• Canaccord Downgrades Regis Resources Ltd. (RRL:AU) (RGRNF) to Hold